PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 27.75
+1.60 (6.12%)
Aug 14, 2025, 5:31 PM CET
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 862.73 million as of August 14, 2025. Its market cap has decreased by -7.25% in one year.
Market Cap
862.73M
Enterprise Value
895.06M
Revenue
344.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.75
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 862.73M, a decrease of -66.69%. That is a compound annual growth rate of -22.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 862.73M | -7.90% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
| Apr 29, 2021 | 2.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 214.27B |
| Novartis AG | 188.78B |
| Lonza Group AG | 38.89B |
| Alcon | 34.73B |
| Galderma Group AG | 31.01B |
| Sandoz Group AG | 20.60B |
| Straumann Holding AG | 15.19B |
| Sonova Holding AG | 13.47B |